What is S-23 Injectable?
S-23 is one of the most potent SARMs available, originally developed as a male contraceptive candidate due to its strong suppression of FSH and LH at research doses. As an injectable it operates at a significantly higher effective level than its oral counterpart, delivering more pronounced anabolic and androgenic effects with greater bioavailability. S-23 binds androgen receptors with very high affinity, producing extreme hardness, density, and vascularity that makes it particularly well-suited to cutting phases. It is not a compound to take lightly. The side effect burden is real and requires proper planning, a test base, and PCT. Users who come in prepared and use it correctly can see dramatic physique changes in a short period.
Mechanisms of Action
High-affinity androgen receptor binding with S-23 exhibiting one of the strongest androgen receptor binding affinities among SARMs, driving potent anabolic signaling in muscle tissue with minimal selectivity margin compared to softer compounds in the class
FSH and LH suppression via strong HPG axis feedback, which forms the basis of its original contraceptive research application and the reason a test base is non-negotiable during use
Nitrogen retention and protein synthesis upregulation through androgen receptor-mediated gene expression, supporting lean muscle accumulation and preservation during a caloric deficit
Fat oxidation support contributing to the hardening and drying effect users experience, particularly when run during a cut where the compound's tendency to produce a dense and vascular look is most visible
Benefits
Extreme vascularity and hardness S-23's most defining characteristic, producing a dry, dense, and striated look that is difficult to achieve with other compounds at comparable doses
Significant strength increases accompanying the physique changes, with users reporting substantial performance gains even in a caloric deficit
Lean muscle mass gains particularly effective during a cut where the goal is retaining and building quality muscle while reducing body fat simultaneously
Heightened aggression and drive in training reported by most users, which can translate to more productive and intense sessions when channeled appropriately
Dosing
Level | Dose | Timing |
|---|---|---|
Beginner | 5–10 mg ED or EOD | 45 minutes pre-training |
Intermediate | 15 mg ED or EOD | 45 minutes pre-training |
Advanced | 20 mg+ ED or EOD | 45 minutes pre-training |
Administer via intramuscular injection approximately 45 minutes before training. S-23 is best deployed during a cut rather than a bulk, as the physique effects are most dramatic when body fat is already being reduced. A testosterone base is not optional on this compound given the degree of FSH and LH suppression it produces.
Warning: S-23 will suppress natural testosterone production significantly. Running it without a test base will leave you with near-zero endogenous testosterone and all the symptoms that come with it. A structured PCT is required after every cycle. Monitor lipids, watch for excessive aggression, and have a joint support formula on hand as injury risk increases with the rapid strength gains this compound produces.
Safety Profile
Infertility and testosterone suppression the most serious concern with S-23, which was specifically designed as a contraceptive agent due to its FSH and LH suppression; a test base and PCT are essential
Dyslipidemia with potentially significant negative shifts in LDL and HDL cholesterol profiles requiring monitoring throughout the cycle
Increased aggression and anger more pronounced than with most SARMs, linked to its high androgen receptor affinity and androgenic activity
Hair loss possible particularly in users with a genetic predisposition to androgenic alopecia, consistent with its potent AR binding activity
Acne reported by some users, driven by androgenic stimulation of sebaceous glands
Insomnia noted during use, which can compound recovery issues and should be managed proactively
Physique flattening if not run correctly or in the wrong context, S-23 can cause a flat appearance due to its drying effects stripping intramuscular water along with subcutaneous water
Joint pain and injury risk elevated as strength gains can outpace connective tissue adaptation; stacking with a joint support formula is recommended throughout the cycle
Citations
Jones, A., et al. Preclinical characterization of S-23 as a selective androgen receptor modulator. PubMed. https://pubmed.ncbi.nlm.nih.gov/20593435/
Disclaimer: The information provided is intended solely for educational purposes and should not be considered a replacement for professional medical advice. All compounds referenced are not for human consumption.
